Based on the company's latest reports for March 2026, the current 12-month EPS is $3.87. Zimmer Biomet Holdings's earnings per share in 2025 was reported at $3.56, marking a decline from $4.45 in 2024. In the quarterly report ending on Mar 31, 2026, ZBH's earnings per share amounted to $1.22.
Zimmer Biomet Holdings had an yealy earnings per share of $3.56, showing a decline of 20% from $4.45 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $1.22, showing a 32.6% increase compared to the same quarter last year. The trailing twelve months EPS for ZBH is $3.87 as of March 2026. Zimmer Biomet Holdings's full-year EPS for 2024 was $4.45, a 9.4% decline compared to the previous year.
Zimmer Biomet Holdings has recorded a growth in earnings per share of 32.6% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 47.9% per year. When assessed over a ten-year period, ZBH's average EPS annual growth was 16.4%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BSX Boston Scientific Corp | 20.25 | 55.6% | 63.3% | N/A |
| ZBH Zimmer Biomet Holdings Inc | 22.52 | -20% | 47.9% | N/A |
| COO Cooper Companies Inc | 31.04 | -4.6% | -1.2% | 9.2% |
| SYK Stryker Corp | 34.44 | 8% | 10.9% | 14.8% |
| EW Edwards Lifesciences Corp | 46.26 | -73.6% | -9.2% | 6.9% |
All data is based on quarterly TTM periods, unless otherwise specified.